A Phase I First-in-Human Study of ABBV-011, a Seizure-Related Homolog Protein 6-Targeting Antibody-Drug Conjugate, in Patients With Small Cell Lung Cancer

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

Clinical Cancer Research

Topics

Medicine

Cancer Oncology

Epidemiology

Internal Medicine

Surgery

Show all topics

DOI

10.1158/1078-0432.ccr-24-1547

License

CC-BY-NC-ND